APA (7th ed.) Citation

A, D., R, K., M, S., R, K., S, P., & AI, O. (2025). Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): The interplay of gut microbiome, insulin resistance, and diabetes. Frontiers in medicine, 12, 1618275. https://doi.org/10.3389/fmed.2025.1618275

Chicago Style (17th ed.) Citation

A, Dua, Kumari R, Singh M, Kumar R, Pradeep S, and Ojesina AI. "Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): The Interplay of Gut Microbiome, Insulin Resistance, and Diabetes." Frontiers in Medicine 12 (2025): 1618275. https://doi.org/10.3389/fmed.2025.1618275.

MLA (9th ed.) Citation

A, Dua, et al. "Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): The Interplay of Gut Microbiome, Insulin Resistance, and Diabetes." Frontiers in Medicine, vol. 12, 2025, p. 1618275, https://doi.org/10.3389/fmed.2025.1618275.